Page last updated: 2024-11-03

ritanserin and Aura

ritanserin has been researched along with Aura in 1 studies

Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shin, EJ1
Jeong, JH1
Chung, YH1
Kim, TW1
Shin, CY1
Kim, WK1
Ko, KH1
Kim, HC1

Other Studies

1 other study available for ritanserin and Aura

ArticleYear
Decrease in the kainate-induced wet dog shake behavior in genetically epilepsy-prone rats: possible involvement of an impaired synaptic transmission to the 5-HT(2A) receptor.
    Journal of pharmacological sciences, 2009, Volume: 110, Issue:3

    Topics: Animals; Behavior, Animal; Cytoskeletal Proteins; Disease Models, Animal; Epilepsy; Kainic Acid; Ner

2009